IPG Photonics (IPGP) AI Stock Analysis

Compare

699 Followers

Top Page

IPG Photonics

(NASDAQ:IPGP)

Select Model

Neutral 64 (OpenAI - 5.2)

Rating:64Neutral

Price Target:

$141.00

▲(7.17% Upside)

Action:ReiteratedDate:02/25/26

The score is driven primarily by strong technical momentum and an exceptionally strong, low-risk balance sheet. Offsetting these positives are weak recent cash-flow conversion and a very expensive valuation (high P/E), with tariffs and a patent ruling adding near-term margin and legal overhangs.

Positive Factors

Balance Sheet Strength

IPG's essentially debt-free balance sheet and large cash reserves (~$839M cash/short-term investments) provide durable financial flexibility. This reduces refinancing risk, funds R&D/CapEx and buybacks, and lets the company weather cyclicality without leverage-driven constraints.

Diversifying Revenue Mix

Growing contribution from emerging and medical products shifts revenue away from cyclical materials-processing exposure. Higher-margin medical systems and consumables increase recurring revenue potential and expand addressable markets, supporting steadier top-line and margin expansion over multiple years.

Technology & Product Leadership

Consistent product wins, novel demos and awards signal sustained R&D and IP advantages. Combined with new product launches (Crossbow) and expanded R&D/manufacturing, this underpins differentiated offerings, supports premium positioning and opens durable adjacencies like defense and advanced microprocessing.

Negative Factors

Weak Cash Conversion

A decline in operating cash flow and a slightly negative free cash flow in 2025 reduce internal funding capacity and increase sensitivity to earnings volatility. This can limit organic investment pacing, constrain discretionary capital returns, and elevate reliance on cash reserves for near-term growth plans.

Tariff-Driven Margin Pressure

Persistent tariffs and higher product costs are compressing gross margins and undercutting recovery toward historic levels. Structural margin pressure forces ongoing pricing, sourcing or product-cost actions, delaying the company’s ability to scale gross margins above 40% as fixed-cost absorption improves.

European Patent Ruling Risk

A regional patent ruling creates legal uncertainty and potential remedies (injunctions, recalls, damages). Even if current revenue impact is small, prolonged litigation risks remediation costs, customer disruption and distraction for engineering/sales teams across Europe, adding structural legal overhang.

IPG Photonics (IPGP) vs. SPDR S&P 500 ETF (SPY)

Market Cap

$5.55B

Dividend YieldN/A

Average Volume (3M)626.92K

Price to Earnings (P/E)180.3

Beta (1Y)1.25

Revenue Growth-7.49%

EPS GrowthN/A

CountryUS

Employees4,740

SectorTechnology

Sector Strength88

IndustrySemiconductors

Share Statistics

EPS (TTM)0.31

Shares Outstanding42,191,353

10 Day Avg. Volume867,867

30 Day Avg. Volume626,919

Financial Highlights & Ratios

PEG Ratio-0.83

Price to Book (P/B)1.43

Price to Sales (P/S)3.04

P/FCF Ratio-883.02

Enterprise Value/Market Cap0.93

Enterprise Value/Revenue5.12

Enterprise Value/Gross Profit13.47

Enterprise Value/Ebitda51.13

Forecast

1Y Price Target

$152.25

Price Target Upside15.72% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering7

EPS Forecast (FY)1.59

Revenue Forecast (FY)$1.09B

IPG Photonics Business Overview & Revenue Model

Company DescriptionIPG Photonics Corporation develops, manufactures, and sells various high-performance fiber lasers, fiber amplifiers, and diode lasers used in various applications primarily in materials processing worldwide. The company's laser products include hybrid fiber-solid state lasers with green and ultraviolet wavelengths; fiber pigtailed packaged diodes and fiber coupled direct diode laser systems; high-energy pulsed lasers, multi-wavelength and tunable lasers, and single-polarization and single-frequency lasers; and high-power optical fiber delivery cables, fiber couplers, beam switches, chillers, scanners, and other accessories. It also provides erbium-doped fiber and Raman amplifiers, and integrated communications systems, which are deployed in broadband networks; and ytterbium and thulium specialty fiber amplifiers and broadband light sources. In addition, the company offers integrated laser systems; 2D compact flat sheet cutter systems and multi-axis systems; welding seam stepper and picker, a fiber laser welding tool; high precision laser systems; specialized fiber laser systems; and optical transceiver and transponder modules for interconnecting electronic equipment, including Ethernet switches, IP routers and DWDM/SONET/SDH optical transport modules within telecommunications, cable multi-system operators, and data center networking applications. It's lasers and amplifiers are also used in materials processing, communications, and medical and advanced applications. The company markets its products to original equipment manufacturers, system integrators, and end users through direct sales force, as well as through agreements with independent sales representatives and distributors. IPG Photonics Corporation was founded in 1990 and is headquartered in Oxford, Massachusetts.

How the Company Makes MoneyIPG Photonics generates revenue primarily through the sale of its fiber laser systems and related products. The company has a diversified revenue model that includes the sale of laser systems, which constitute the largest portion of its sales, along with related services such as installation, maintenance, and repairs. Additionally, IPG offers components like laser diodes and amplifiers, which serve as significant revenue streams. The company benefits from strong demand across various sectors, including industrial manufacturing, automotive, aerospace, and medical devices. Key partnerships with manufacturers and distributors enhance its market reach. Furthermore, the growth in automation and technological advancements in laser applications contribute to its earnings, as industries increasingly adopt laser technology for efficiency and precision.

IPG Photonics Key Performance Indicators (KPIs)

Any

Revenue by Geography

Revenue by Geography
Breaks down sales by region, showing exposure to key markets like China, North America, and Europe. Geographic mix matters for growth prospects and risks: heavy reliance on a single region can amplify impacts from local downturns, trade measures, or currency swings, while diversification points to broader market reach and resilience.

Chart InsightsIPG’s revenue mix is shifting decisively toward Asia — the region is now the primary growth engine, fueled by welding and battery demand — while North America and Europe have softened and become more lumpy. Management says the North America sequential drop reflects timing of large orders, implying short-term volatility rather than structural collapse, but elevated operating expenses and a ~140bp tariff headwind amplify execution risk if Asia slows. New medical and directed‑energy wins diversify end markets, yet near-term earnings depend on margin recovery and order timing.

Data provided by:

The Fly

IPG Photonics Earnings Call Summary

Earnings Call Date:Feb 12, 2026

(Q4-2025)

% Change Since: |

Next Earnings Date:May 05, 2026

Earnings Call Sentiment Positive

The call conveyed a predominantly positive tone: management reported a strong Q4 beat, the company's first full-year revenue growth since 2021, growing contribution from higher-margin and emerging markets (medical, micromachining, advanced applications), solid cash and no debt, and product/technology milestones (awards, BUV demo, Crossbow launch). Headwinds were acknowledged—tariff-related margin pressure, under-absorption from inventory decisions, higher product costs, and some timing-related order shipping into future quarters—along with increased 2026 CapEx. Overall, the positive operational momentum, diversified growth drivers, robust balance sheet, and book-to-bill >1 outweigh the margin and timing challenges, but management remains cautiously optimistic.

Q4-2025 Updates

Positive Updates

Strong Q4 Revenue Beat

Revenue of $274 million in Q4 2025, +17% year-over-year and +9% sequentially; foreign currency added ~$6 million (≈2%) in the quarter.

First Full-Year Revenue Growth Since 2021

Full-year 2025 revenue grew 3%, marking the company's first annual revenue increase since 2021.

Emerging Growth Mix Expanding

Products outside traditional materials processing represented ~14% of total revenue for 2025; emerging growth products accounted for 54% of total sales in Q4 (up from 52% prior quarter, matching a record).

Medical Business Momentum

Medical sales grew 21% in 2025 to a record level; received FDA clearance for next-generation urology system (StoneSense) and began shipments in Q4; management expects further product launches and potential to expand recurring consumable revenue.

Materials Processing & Welding Strength

Materials processing revenue in Q4 +17% YoY and +6% sequentially; welding showed region-specific strength with increased sales in Asia/China driven by rebounding battery investments and a shift toward stationary storage use cases.

Regional Order Strength

North America sales +23% YoY and +21% sequentially; Asia sales +19% YoY and +5% sequentially; Europe improved +7% YoY and +8% sequentially with notable Clean Laser synergies.

Profitability, Cash Position, and Capital Returns

Adjusted EBITDA of $41 million in Q4 (above guidance), GAAP net income $13 million ($0.31/diluted), adjusted net income $20 million ($0.46/diluted). Strong balance sheet with $839 million cash/cash equivalents/short-term investments, $77 million long-term investments, no debt, positive free cash flow in Q4, $53 million of share repurchases in 2025 and a new $100 million buyback authorization.

Product and Technology Recognition

Received a Prism Award for a new 8 kW single-mode laser; demonstrated a compact 148 nm vacuum ultraviolet BUV laser source—significant technological milestones supporting differentiated roadmap.

Directed Energy Progress

Launched Crossbow (3 kW 'Mini') scalable laser-defense system for group 1/2 drones, formed IPG Defense, and opened an R&D/manufacturing facility in Huntsville, indicating early commercial traction and a roadmap to higher-power variants.

Negative Updates

Gross Margin Pressure from Tariffs and Cost Absorption

GAAP gross margin was 36.1% and adjusted gross margin 37.6% in Q4; tariffs reduced gross margin by ~200 basis points year-over-year (50 bps worse than expected) and under-absorption of fixed costs (planned inventory management) further depressed margins versus revenue level.

Operating Income and One-Time Costs

GAAP operating income was modest at $3 million in Q4; results included approximately $4 million of one-time costs and year-over-year operating expense increases due to strategic investments.

Product Costs and Tariff Persistence

Higher product costs contributed to gross margin decline; management expects tariff headwinds to persist into 2026 (guidance assumes ~150 bps tariff impact in Q1) requiring pricing and cost actions to offset.

Segment & Timing Headwinds

Full-year materials processing sales were flat as lower cutting sales were offset by growth in cleaning/additive/welding; cutting revenue slightly lower YoY and micromachining was impacted by timing of customer orders—some bookings (medical/systems) scheduled to ship beyond Q1, creating near-term revenue timing risk.

CapEx Timing and Increased 2026 Spend

Major fiber manufacturing facility spend was delayed (~$50 million moved into 2026); expected CapEx for 2026 increased to $90–$100 million, introducing timing variability and higher near-term capital deployment.

Europe Recovery Still Lagging

Although Europe improved sequentially (+8% Q4), management characterized it as weaker relative to North America and Asia and still behind in recovery per PMI and order trends.

Company Guidance

The company guided for Q1 2026 revenue of $235 million to $265 million with adjusted gross margin of 37%–39% (including an estimated tariff headwind of ~150 basis points), operating expenses of $90 million–$92 million, adjusted EBITDA of $25 million–$40 million, and adjusted EPS of $0.10–$0.40 on ~42.5 million diluted shares; management noted book‑to‑bill was firmly above one (though some medical/systems bookings will ship after Q1), expects tariffs to persist at a moderated level, anticipates operating expenses to increase modestly through the year to accelerate growth initiatives, and reaffirmed 2026 CapEx of $90 million–$100 million (with underlying CapEx ≈5% of revenue) while highlighting margin upside as revenue growth improves fixed‑cost absorption toward the company’s >40% gross‑margin target.

IPG Photonics Financial Statement Overview

Summary

Overall financials are mixed: a very strong, no-debt balance sheet (Score 88) provides resilience, but profitability is still in recovery (Income Statement Score 54) and cash generation weakened with slightly negative free cash flow in 2025 (Cash Flow Score 46).

Income Statement

Neutral

Profitability rebounded in 2025 (annual) to a modest net profit after a significant loss in 2024, but earnings quality remains weaker than the company’s earlier peak years (2020–2023) when operating and net margins were substantially higher. Revenue growth turned positive in 2025 following declines in 2022–2024, yet the multi-year trend still reflects a smaller revenue base versus 2021–2022 and meaningfully lower operating leverage. Overall, the income statement shows recovery, but not yet a return to historical strength.

Balance Sheet

Very Positive

The balance sheet is a clear strength: the company carries essentially no debt (debt-to-equity near zero and total debt at $0 in 2025), supported by a large equity base relative to total assets. While returns on equity weakened sharply in 2024 and remain low in 2025 due to depressed profitability, financial risk from leverage is minimal and the capital structure provides flexibility to endure cyclical pressure and fund investment.

Cash Flow

Neutral

Cash generation became less supportive in 2025 (annual): operating cash flow fell materially versus 2024 and free cash flow turned slightly negative, signaling weaker cash conversion despite returning to positive net income. Prior years (2020–2023) showed consistently positive free cash flow, but the latest year’s deterioration and negative free cash flow growth indicate higher volatility and reduced internal funding capacity in the near term.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.00B	977.13M	1.29B	1.43B	1.46B
Gross Profit	381.46M	338.15M	541.70M	555.41M	696.40M
EBITDA	111.95M	75.92M	301.19M	321.97M	449.09M
Net Income	31.10M	-181.53M	218.88M	109.91M	278.42M
Balance Sheet
Total Assets	2.42B	2.29B	2.70B	2.74B	3.17B
Cash, Cash Equivalents and Short-Term Investments	839.33M	930.19M	1.18B	1.18B	1.51B
Total Debt	0.00	17.96M	18.26M	38.05M	58.13M
Total Liabilities	296.15M	264.79M	283.51M	357.92M	423.32M
Stockholders Equity	2.13B	2.02B	2.42B	2.39B	2.75B
Cash Flow
Free Cash Flow	-3.45M	149.37M	185.50M	102.51M	266.59M
Operating Cash Flow	75.34M	247.90M	295.99M	212.65M	389.70M
Investing Cash Flow	-265.23M	208.73M	-237.55M	296.95M	-416.28M
Financing Cash Flow	-54.19M	-339.62M	-236.38M	-514.55M	-125.07M

IPG Photonics Technical Analysis

Technical Analysis Sentiment

Positive

Last Price131.57

Price Trends

50DMA

96.15

Positive

100DMA

89.64

Positive

200DMA

82.12

Positive

Market Momentum

MACD

11.73

Positive

RSI

60.78

Neutral

STOCH

34.45

Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IPGP, the sentiment is Positive. The current price of 131.57 is above the 20-day moving average (MA) of 121.74, above the 50-day MA of 96.15, and above the 200-day MA of 82.12, indicating a bullish trend. The MACD of 11.73 indicates Positive momentum. The RSI at 60.78 is Neutral, neither overbought nor oversold. The STOCH value of 34.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IPGP.

IPG Photonics Risk Analysis

IPG Photonics disclosed 34 risk factors in its most recent earnings report. IPG Photonics reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added 0 New Risks

IPG Photonics Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PLAB	78 Outperform	$2.17B	15.96	11.67%	―	-2.04%	8.84%
NVMI	74 Outperform	$13.95B	54.97	23.08%	―	39.37%	40.87%
OLED	70 Outperform	$5.02B	21.02	14.32%	1.52%	-0.58%	-6.67%
SMTC	69 Neutral	$8.35B	296.58	13.39%	―	20.60%	―
IPGP	64 Neutral	$5.55B	180.33	1.50%	―	-7.49%	―
ASX	63 Neutral	$54.00B	40.41	12.53%	2.29%	8.01%	10.41%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%

* Technology Sector Average

Performance Comparison

IPGP

IPG Photonics

131.57

73.30

125.79%

ASX

ASE Technology Holding Co

24.29

14.80

155.98%

NVMI

Nova

438.86

210.80

92.43%

PLAB

Photronics

37.43

17.54

88.19%

SMTC

Semtech

90.22

54.64

153.57%

OLED

Universal Display

106.69

-37.22

-25.86%

IPG Photonics Corporate Events

Business Operations and StrategyLegal Proceedings

IPG Photonics Faces European Patent Ruling, Plans Appeal

Negative

Feb 25, 2026

On February 25, 2026, IPG Photonics announced that the Local Division of the Unified Patent Court in Mannheim, Germany ruled certain designs of its adjustable mode beam lasers used in welding and cutting infringed Trumpf’s European Patent 2,951,625. The decision affects specific AMB laser products sold in seven UPC member states, including Germany, France and Italy, but the company said the impact is limited to less than 1% of its total sales.

IPG is implementing contingency measures to support customers using the affected AMB products, while emphasizing that its broader laser portfolio was not involved in the case and remains widely available. The company has stated it respectfully disagrees with the ruling and intends to appeal to the UPC Court of Appeal, leaving remedies such as injunctions, recalls and damages to be determined at a later stage.

The most recent analyst rating on (IPGP) stock is a Hold with a $141.00 price target. To see the full list of analyst forecasts on IPG Photonics stock, see the IPGP Stock Forecast page.

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 25, 2026